Position in LLY
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$20,661,382
+$1,539,365 QoQ
Shares Held
17,226
-17.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#875
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEVILLE RODIE & SHAW INC holds $104,588,687 across 10 Drug Manufacturers - General names. LLY ranks #3 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
168,188 | $42,714,706 | |
| 2 | ABBV |
AbbVie Inc.
|
88,895 | $22,369,537 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
17,226 | $20,661,382 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,699 | $11,269,321 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
39,489 | $2,275,356 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
14,844 | $1,875,390 | |
| 7 | PFE |
Pfizer Inc
|
64,658 | $1,556,964 | |
| 8 | NVS |
Novartis AG
|
5,610 | $879,199 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,661,382 | 17,226 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $19,122,017 | 20,790 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $20,599,467 | 19,168 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $10,778,901 | 14,127 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $12,463,124 | 15,988 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $12,463,807 | 15,091 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $11,603,932 | 15,031 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $13,230,627 | 14,934 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $13,918,406 | 15,373 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $11,798,541 | 15,166 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $8,423,194 | 14,450 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $6,998,803 | 13,030 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $5,895,078 | 12,570 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $903,194 | 2,630 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $709,729 | 1,940 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $412,271 | 1,275 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $389,076 | 1,200 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $343,644 | 1,200 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $331,464 | 1,200 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $277,260 | 1,200 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $275,424 | 1,200 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $224,184 | 1,200 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $202,608 | 1,200 | Shares | Sole | 2021-03-04 | |
| No filing history on record for this holder in this stock. | ||||||